Triethoxyoctylsilane

CAS No. 2943-75-1

Triethoxyoctylsilane( Triethoxycaprylylsilane | Triethoxycaprylylsilane | Oleth-30 | NSC 42964 )

Catalog No. M27141 CAS No. 2943-75-1

Triethoxycaprylylsilane is an organically modified silane that has been found to aggregate in the form of normal micelles as well as reverse micelles.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 37 In Stock

Biological Information

  • Product Name
    Triethoxyoctylsilane
  • Note
    Research use only, not for human use.
  • Brief Description
    Triethoxycaprylylsilane is an organically modified silane that has been found to aggregate in the form of normal micelles as well as reverse micelles.
  • Description
    Triethoxycaprylylsilane is an organically modified silane that has been found to aggregate in the form of normal micelles as well as reverse micelles. Triethoxycaprylylsilane is commonly used in plastic applications.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Triethoxycaprylylsilane | Triethoxycaprylylsilane | Oleth-30 | NSC 42964
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TLR7/8/9
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2943-75-1
  • Formula Weight
    276.492
  • Molecular Formula
    C14H32O3Si
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (36.17 mM)
  • SMILES
    CCCCCCCC[Si](OCC)(OCC)OCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mussari CP, et al. Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9). ACS Med Chem Lett. 2020 Jul 29;11(9):1751-1758.
molnova catalog
related products
  • Nemorubicin

    Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?

  • GCN2-IN-1

    GCN2-IN-1 is an effective GCN2 inhibitor and can be used in research on the treatment of cancer as a chemotherapeutic agent.

  • ODQ

    ODQ is an effective and selective soluble guanylyl cyclase (sGC) inhibitor.